Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies.
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the ongoing coronavirus disease (COVID-19) pandemic which is characterized by respiratory illness and severe pneumonia, and currently accounts for > 2.5 million deaths worldwide. Recently, diverse mutations in the spi...
Main Authors: | Kaewta Rattanapisit, Christine Joy I Bulaon, Narach Khorattanakulchai, Balamurugan Shanmugaraj, Kittikhun Wangkanont, Waranyoo Phoolcharoen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0253574 |
Similar Items
-
Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies
by: Kaewta Rattanapisit, et al.
Published: (2021-01-01) -
Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro
by: Balamurugan Shanmugaraj, et al.
Published: (2020-11-01) -
Emergence of monkeypox: Another concern amidst COVID-19 crisis
by: Balamurugan Shanmugaraj, et al.
Published: (2022-01-01) -
SARS-CoV-2 variants: A continuing threat to global health
by: Balamurugan Shanmugaraj, et al.
Published: (2022-01-01) -
Antitumor effect of plant-produced anti-CTLA-4 monoclonal antibody in a murine model of colon cancer
by: Christine Joy I. Bulaon, et al.
Published: (2023-08-01)